Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 2 September 1994:
Vol. 265. no. 5177, pp. 1389 - 1391
DOI: 10.1126/science.8073280
Prev | Table of Contents | Next

Articles

Rotavirus vaccines: success by reassortment?

RI Glass, J Gentsch, and JC Smith

No abstract or summary view of this item is available. To view the full-text version, follow this link.

Article topics:

  • Medicine..Cholera
  • Religious Studies..Death
  • Medicine..Child Mortality
  • Medicine..Pediatric Diarrhea
  • Medicine..Mortality and Morbidity
  • Virology..Rotaviruses
  • Sociology..Mortality


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Development and Validation of DNA Microarray for Genotyping Group A Rotavirus VP4 (P[4], P[6], P[8], P[9], and P[14]) and VP7 (G1 to G6, G8 to G10, and G12) Genes.
S. Honma, V. Chizhikov, N. Santos, M. Tatsumi, M. do Carmo S. T. Timenetsky, A. C. Linhares, J. D. P. Mascarenhas, H. Ushijima, G. E. Armah, J. R. Gentsch, et al. (2007)
J. Clin. Microbiol. 45, 2641-2648
   Abstract »    Full Text »    PDF »
Rotavirus Serotype G9 Strains Belonging to VP7 Gene Phylogenetic Sequence Lineage 1 May Be More Suitable for Serotype G9 Vaccine Candidates than Those Belonging to Lineage 2 or 3.
Y. Hoshino, R. W. Jones, J. Ross, S. Honma, N. Santos, J. R. Gentsch, and A. Z. Kapikian (2004)
J. Virol. 78, 7795-7802
   Abstract »    Full Text »    PDF »
Protective Efficacy of a Sulfated Sialyl Lipid (NMSO3) against Human Rotavirus-Induced Diarrhea in a Mouse Model.
K. Takahashi, K. Ohashi, Y. Abe, S. Mori, K. Taniguchi, T. Ebina, O. Nakagomi, M. Terada, and S. Shigeta (2002)
Antimicrob. Agents Chemother. 46, 420-424
   Abstract »    Full Text »    PDF »
Vaccines and Vaccination.
G. Ada (2001)
N. Engl. J. Med. 345, 1042-1053
   Full Text »    PDF »
Probing the Structure of Rotavirus NSP4: a Short Sequence at the Extreme C Terminus Mediates Binding to the Inner Capsid Particle.
J. A. O'Brien, J. A. Taylor, and A. R. Bellamy (2000)
J. Virol. 74, 5388-5394
   Abstract »    Full Text »    PDF »
Rotavirus Spike Protein VP4 Is Present at the Plasma Membrane and Is Associated with Microtubules in Infected Cells.
M. Nejmeddine, G. Trugnan, C. Sapin, E. Kohli, L. Svensson, S. Lopez, and J. Cohen (2000)
J. Virol. 74, 3313-3320
   Abstract »    Full Text »    PDF »
The Memory B Cell Subset Responsible for the Secretory IgA Response and Protective Humoral Immunity to Rotavirus Expresses the Intestinal Homing Receptor, {alpha}4{beta}7.
M. B. Williams, J. R. Rose, L. S. Rott, M. A. Franco, H. B. Greenberg, and E. C. Butcher (1998)
J. Immunol. 161, 4227-4235
   Abstract »    Full Text »    PDF »
Efficacy of the Rhesus Rotavirus-Based Quadrivalent Vaccine in Infants and Young Children in Venezuela.
I. Perez-Schael, M. J. Guntinas, M. Perez, V. Pagone, A. M. Rojas, R. Gonzalez, W. Cunto, Y. Hoshino, and A. Z. Kapikian (1997)
N. Engl. J. Med. 337, 1181-1187
   Abstract »    Full Text »    PDF »
A Vaccine against Rotavirus -- When is Too Much Too Much?.
G. T. Keusch and R. A. Cash (1997)
N. Engl. J. Med. 337, 1228-1229
   Full Text »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)